RankingsPricing
  1. US-listed companies
  2. CollPlant Biotechnologies Ltd

CollPlant Biotechnologies LtdCLGN

Market cap
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Net income (loss)-11--0-17
Depreciation and amortization--11
Interest from Short term deposits--00
Share-based compensation to employees and consultants--22
Exchange differences on cash and cash equivalents-00-1
Financial income related to financial instruments--0-0-
Decrease (increase) in trade receivables-1-1-0
Decrease (increase) in inventories-0-00
Decrease (increase) in other receivables--000
Decrease in operating right of use assets---0-0
Increase (decrease) in trade payables--000
Decrease in lease liabilities---0-1
Increase (decrease) in accrued liabilities and other payables-1-00
Decrease in deferred revenues--1-0-0
Net cash provided by (used in) operating activities--43-14
Capitalization of intangible assets-000
Purchase of property and equipment-011
Repayment of a short term deposits---50
Investment in short term deposits--3020
Proceeds from sale of property and equipment--0-
Net cash provided by (used in) investing activities--1-3229
Proceeds from issuance of shares and warrants less issuance expenses-433-
Loan repaid-0--
Exercise of options and warrants into shares-062
Net cash provided by financing activities-4392
Exchange differences on cash and cash equivalents and restricted deposits-00-1
Net increase (decrease) in cash and cash equivalents and restricted deposits---16
Conversion of pre-paid warrants to ordinary shares-0--
Right of use assets recognized with corresponding lease liabilities-010
Classification of issuance costs liability to equity--0-
Capitalization of Share-based compensation to inventory---0
Cash paid during the year for taxes---0